Reposted from the I-HUB site.

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat
Reposted from the I-HUB site.


















skeptical159







Wednesday, March 07, 2012 11:47:30 PM
Re: $b_rich$ post# 53546

Post # of  90497

The Mods don't want you to read this, apparently, since they almost immediately deleted my first post. I can understand if you remove profanity or pure speculation, but this is exactly the set of facts that should be instructive to the typical investor but they would prefer that you the investor were not aware of. If you get a chance to read this please copy and paste into a new message if you feel it is worthwhile. 


I posted some of the same concerns that I will expound upon later in a post last night, that generated a fairly ignorant response from Warmy and did not address the issues at all, so my hope is that if you actually have information that would confirm that this is not a scam that you would be willing to address these questions. 

I think as investors most would define a scam as a company created as a front without any true business capabilities or products. And here you're right, GDSM is not a scam in this sense. However I think a scam could also be defined as a set of individuals with clear conflicts of interest who set up a company to sell massive amounts of shares and reap the benefit of a perceived beneficial business plan based on false or manipulated assays. And here unfortunately is the category that I believe GDSM falls into, but right now that belief is just based on extensive circumstantial evidence so if there are facts to the contrary please let us know. 

What I do know is that GDSM share prices have risen primarily based on two things, on the basis of a seemingly positive profile (including the Technical Summary by Don Jenkins, and business plans) of the Gold Star Mine from McCoy Gold Mines, LLC, and the promise of funding for placement of a mine at the Gold Star claims through a joint venture between GDSM and Western Sierra. If both those situations prove fraudulent then I don't think anyone would disagree that there would be no reason to buy GDSM stock. 

So let's look first at the profile from McCoy Gold Mines, and it becomes immediately apparent how tangled this web is. The company that has supposedly provided this unbiased 3rd party review of the Gold Star claims is run by  Jason Lee and Sam Cooper. The scary thing from an investor's perspective is that Sam Cooper happens to be related to  Jason Cooper, the former CEO of GDSM. So the only positive review of this Gold Star claim was generated by the family member of the CEO of the company now trying to convince you the investor to buy their stock. And this is only the beginning. Don Jenkins is the, also apparently unbiased 3rd party, source of the technical summary on McCoy's site. Jenkins is not only involved in a company called Arizona Gold Corp. but also happens to be a large investor and primary stockholder in a little company called Western Sierra. So now, the company involved in the joint venture is basically run by the same guy who provided the unbiased review of the property and has also been allowed to sell $400,000 worth of GDSM stock to fund this joint venture. I wonder where that money is going. And just in case you thought that was all,  Jason Lee (from McCoy... I know this is quite a web) happens to be related to John Lee, who is a VP at Arizona Gold Corp. The coincidences are just amazing (but in business we don't tend to call those coincidences they get called righty... fraud). 

But now onto the joint venture between GDSM and Western Sierra. We have already established that Don Jenkins was involved in both the technical analysis phase and the formation of the joint venture as a primary stockholder in Western Sierra... so obviously he has a significant amount to gain by pumping this stock up to sell available shares. However, the corruption is just starting. Michael Chaffee and Dennis Atkins just happen to sit on the board of GDSM together, and guess where else they happen to sit on a board (and hold some esteemed titles)... wait for it, you guessed it Western Sierra. I can just imagine the conversation going on in Michael's head as he considered whether to vote for the joint venture as a GDSM board member... (Do you think this would be a good idea Michael (Western Sierra)?, Why yes it seems like a spectacular idea (GDSM), we can prop up the stock price and sell all our interest into the market for far more than we paid., By god Michael (oh who the hell knows at this point) you're right we can get rich by making it look like the companies we own trust each other even though they're run by the same people). 

Where I come from that's not only called a conflict of interest (board members cannot vote on business with companies they own or sit on the board of) but when the same people are in essence running the same two companies and funneling money back and forth... that is, you guessed it once again, why this is a scam.

Green Leaf Innovations, Inc. (GRLF) Stock Research Links

GRLF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 3

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 2

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 2

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading

Top 5 Most Recently Viewed Articles

Big Screen Entertainment Group Unveils Big Screen Capital Fund

Updated Category News Views 138

Introducing Big Screen Capital Big Screen Entertainment Group (OTC:BSEG) has just announced the launch of its new funding subsidiary, Big Screen Capital. This exciting development is set to finance a range of creative projects, including the establishment of the Big Film Fund, as well as two upcoming films and advancements in medical technology. With this strategic move,...

Continue Reading
Air Products Faces Integrity Challenges: A Call for Change

Updated Category News Views 129

Understanding the Recent Calls for Change at Air Products Mantle Ridge has taken a bold step by issuing a shareholder letter that highlights critical concerns regarding Air Products and Chemicals, Inc. The organization, which owns approximately $1.3 billion in shares of Air Products, has pointed out various omissions and misleading statements from the company’s...

Continue Reading
Navigating Key Market Shifts in H2 2026: A Crucial Period

Updated Category News Views 5

The Intensity of Mid-2026: Traders Brace for Impact Traders are steeling themselves for July's rollercoaster of central bank decisions. This isn't just another season; it's a potential market earthquake. When you've got the European Central Bank, Bank of England, and Federal Reserve all signaling rate announcements within days, it's time to pay more than a little...

Continue Reading
Summary of Recent Extraordinary General Meeting Outcomes

Updated Category News Views 158

Results of Extraordinary General Meeting Announcement German High Street Properties A/S is pleased to present the results from the extraordinary general meeting that took place. This meeting marks a significant moment for the company and its shareholders as they come together to discuss essential matters affecting the company's future. Date and Purpose of the Meeting The...

Continue Reading
Tectonic Therapeutics Advances TX45 for Heart Failure Treatment

Updated Category News Views 166

Tectonic Therapeutics Advances TX45 for Heart Health Tectonic Therapeutic, Inc. (NASDAQ: TECX), an innovative biotechnology company, has announced promising outcomes from its Phase 1a trials, which could lead to significant progress in treating Group 2 Pulmonary Hypertension in patients experiencing Heart Failure with Preserved Ejection Fraction (PH-HFpEF). The results...

Continue Reading